Neuro-Cardiogenic Syncope

Guidance for medical examiners when assessing a patient for either a general topic or condition - Neuro-Cardiogenic Syncope.

Aeromedical implications

Effect of aviation on condition

  • Possible trigger for syncopal event eg stress / anxiety, postural change

Effect of condition on aviation

  • Overt incapacitation from loss of consciousness
  • Subtle incapacitation during pre-syncopal phase
  • Distraction due to treatment and symptoms

Approach to medical certification

Based on the condition

  • Number of episodes
  • Pattern of episodes
  • Predictability of episodes
  • Comorbid disease

Based on treatment

  • Evidence for treatment effectiveness
  • Compliance with treatment

Demonstrated stability

  • No episodes during period of surveillance

Risk assessment protocol for significant syncope or pre-syncope - information required

New cases

Copies of the following reports will be required.

  • Ambulance reports
  • Hospital admission notes
  • Imaging reports
  • Hospital discharge letters
  • Eye-witness reports

A report from a Cardiologist will be required.

  • Confirmed diagnosis
  • Clinical status
    • history of syncopal or pre-syncopal episodes
    • triggers
    • symptoms
    • prior to episode - chest pain, palpitations, dyspnoea, visual disturbance
    • following episode - tongue biting, incontinence, post-ictal
    • duration
    • concomitant illnesses
    • family history
    • syncope, epilepsy, sudden death
    • other medical history
  • Investigations conducted
    • exercise ECG (required)
    • 24 hr ECG (required)
    • echocardiogram (required)
    • tilt table test (if indicated)
  • Management
    • treatment
    • side-effects
    • monitoring
  • Follow-up plan
  • Risk of recurrence / incapacitation (with reference to scientific literature where possible).

A report from a Neurologist may be required.

  • Confirmed diagnosis
  • Clinical status
    • history of syncopal or pre-syncopal episodes
    • triggers
    • symptoms
    • prior to episode - chest pain, palpitations, dyspnoea, visual disturbance
    • following episode - tongue biting, incontinence, post-ictal
    • duration
    • concomitant illnesses
    • family history
    • syncope, epilepsy, sudden death
    • other medical history
  • Investigations conducted
    • brain imaging (if indicated)
    • EEG (if indicated)
    • management
    • treatment
    • side-effects
    • monitoring
    • follow-up plan
    • risk of recurrence / incapacitation (with reference to scientific literature where possible).

Renewal

Treating doctor report (GP or specialist).

  • Clinical status
    • further episodes
  • Investigations conducted
  • Management
    • treatment
    • compliance with treatment
    • side-effects
  • Follow-up plan.

Indicative outcomes

Favourable

  • Single episode of syncope or pre-syncope secondary to documented minor illness
  • Single episode of syncope or pre-syncope secondary to trigger not present in aviation environment
  • Absence of syncope or pre-syncope during extended period of surveillance

Unfavourable

  • Significant abnormality on investigation
  • Recurrent and / or unpredictable syncope or pre-syncope

Pilot and controller information

  • Syncope and pre-syncope are aero-medically significant conditions
  • Pilots and controllers who experience syncope and pre-syncope should ground themselves and present to their DAME for review
  • Recurrent episodes may require an extended period of surveillance on the ground
  • Multi-crew restrictions may be required following period of surveillance

Feedback

We value your feedback.

Disclaimer

The clinical practice guidelines is provided by way of guidance only and subject to the clinical practice guidelines disclaimer.

Last updated:
Online version available at: https://www.casa.gov.au//licences-and-certificates/medical-professionals/dames-clinical-practice-guidelines/neuro-cardiogenic-syncope
Back to top of page